Clinical Trials Directory

Trials / Completed

CompletedNCT02172989

Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Benign Breast Neoplasm.

Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Benign Breast Neoplasm ; Observational Pilot Study for 20 Patients.

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
National Cancer Center, Korea · Other Government
Sex
Female
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Near-infrared (NIR) fluorescence imaging using indocyanine green (ICG) has been used for breast cancer surgery such as sentinel lymph node (SLN) mapping and breast cancer localization. In this study, our hypothesis are as following: 1. As inject only indocyanine green (ICG), it provide the surgeon visual guidance to ensure better outcome. 2. indocyanine green (ICG) permitted accurate preoperative and intraoperative detection of the SLNs as well as nonpalpable benign brest lesion in patients with breast cancer.

Detailed description

Indocyanine green, ICG (ICG-fluorescence) * ICG is the most commonly used fluorophore which approve by FDA. * NIR-F imaging with ICG could be used in various surgeries. For example, SLN mapping in breast cancer and localization of liver metastasis, especially superficial lesion * Contains sodium iodide, patients who have history of allergy to iodides should be used as caution. Nonpalpable benign brest lesion localization * New method for the localization and resection of non-palpable breast lesions. * The breast lesion was correctly localized, and the area of ICG corresponded well to the site of the lesions.

Conditions

Timeline

Start date
2014-06-01
Primary completion
2015-04-01
Completion
2015-05-01
First posted
2014-06-24
Last updated
2015-06-19

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02172989. Inclusion in this directory is not an endorsement.

Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Benign Breast Neoplasm. (NCT02172989) · Clinical Trials Directory